We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 11.25 | 11.00 | 11.50 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 11.25 | 10.75 | 11.25 | 1,079,030 | 11:56:37 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0125 | -9.00 | 25.43M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 04/10/2024 | 14:02 | UK RNS | SkinBioTherapeutics PLC Notice of Investor Meet Company Presentation |
| 19/9/2024 | 07:00 | UK RNS | SkinBioTherapeutics PLC Final testing of SkinBiotix by Croda completed |
| 13/8/2024 | 12:49 | UK RNS | SkinBioTherapeutics PLC Holding(s) in Company |
| 08/8/2024 | 07:00 | UK RNS | SkinBioTherapeutics PLC Holding(s) in Company |
| 02/8/2024 | 13:43 | ALNC |  SkinBioTherapeutics lands GBP1.6 million investment to support growth |
| 02/8/2024 | 07:00 | UK RNS | SkinBioTherapeutics PLC Investment of £1.56m from new investors |
| 29/7/2024 | 14:46 | ALNC | SkinBio says trading "better than expected" as revenue grows |
| 29/7/2024 | 07:01 | UK RNS | SkinBioTherapeutics PLC Appointment of Senior Croda VP as Board Advisor |
| 29/7/2024 | 07:00 | UK RNS | SkinBioTherapeutics PLC Full year trading update |
| 23/7/2024 | 15:00 | ALNC | REPEAT: SkinBio announces closure of its convertible bond facility |
1 Year Skinbiotherapeutics Chart |
Intraday Skinbiotherapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
